Screener
Aura Biosciences, Inc. AURA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (102) | (187) |
| Maturities of marketable securities | 55,000 | 30,000 |
| Net cash provided by investing activities | 54,898 | 29,813 |
| Cash flows from financing activities: | ||
| Proceeds from exercise of stock options | 56 | — |
| Proceeds from exercise of common stock warrants | 123 | — |
| Proceeds from ESPP purchases | 121 | 96 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s investing cash flow?
- Aura Biosciences, Inc. (AURA) reported investing cash flow of $54.9M in Q1 2026.
- How has Aura Biosciences, Inc.'s investing cash flow changed year-over-year?
- Aura Biosciences, Inc.'s investing cash flow increased by 84.1% year-over-year, from $29.81M to $54.9M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Aura Biosciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude